Hugging Face's logo

Datasets:
codewithdark
/
SEC-RPT-Panel

Tasks:
Tabular Classification
Text Classification
Modalities:
Document
Tabular
Text
Formats:
csv
Languages:
English
Size:
1K - 10K
Tags:
finance
accounting
sec-edgar
related-party-transactions
fraud-detection
Libraries:
Datasets
pandas
Polars
License:
Dataset card Data Studio Files
xet
 Community
1
SEC-RPT-Panel / raw /aaer /2012 /AAER-3374.txt
codewithdark's picture
codewithdark
Add files using upload-large-folder tool
f980d66 verified
Raw History Blame Contribute Delete
29.4 kB
SEC.gov | Biomet, Inc.
!function(){var e=navigator.userAgent,a=document.documentElement,n=a.className;n=n.replace("no-js","js"),/iPad|iPhone|iPod/.test(e)&&!window.MSStream&&(n+=" ua-ios"),a.className=n}();
{"path":{"baseUrl":"\/","pathPrefix":"","currentPath":"node\/512071","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"gtag":{"tagId":"","consentMode":false,"otherIds":[],"events":[],"additionalConfigInfo":[]},"ajaxPageState":{"libraries":"eJxdT0GOwzAI_JBdn_oei2DkeINNZLC22devlaZS2wtiBhhmcKNUTPo97jxyaXEH3GJpiZrFhQW38A4cMqgeYQGlV19JFTKpQ-kUmvQKXP7I0cO4tC2kPnbg2wVdFslM0SCHPMs3vsEPPD7J6hgOGdPCKJyoRxxqUuePHjLLAuzVjimenRJGSLW08NoBK9LUn6SHlrytVOlcpJShB63QLSpBx_WkOzHNePol4fRQo_qMPvQ36ZXsAmd99lMNr2t_GUR9n60EyX9a_wePd5ns","theme":"uswds_sec","theme_token":null},"ajaxTrustedUrl":[],"gtm":{"tagId":null,"settings":{"data_layer":"dataLayer","include_classes":false,"allowlist_classes":"","blocklist_classes":"","include_environment":false,"environment_id":"","environment_token":""},"tagIds":["GTM-TD3BKV"]},"data":{"extlink":{"extTarget":false,"extTargetAppendNewWindowDisplay":true,"extTargetAppendNewWindowLabel":"(opens in a new window)","extTargetNoOverride":false,"extNofollow":false,"extTitleNoOverride":false,"extNoreferrer":false,"extFollowNoOverride":false,"extClass":"0","extLabel":"(link is external)","extImgClass":false,"extSubdomains":true,"extExclude":".*\\.gov|http:\/\/www.xbrl.org\/utr\/2013-05-17\/utr.xml|http:\/\/www.xbrl.org\/dtr\/type\/numeric-2009-12-16.xsd|http:\/\/www.xbrl.org\/dtr\/type\/nonNumeric-2009-12-16.xsd|https:\/\/secir.secure.force.com\/ombudsman\/OMMSForm","extInclude":"","extCssExclude":".data-exempt","extCssInclude":"","extCssExplicit":"","extAlert":true,"extAlertText":"You are now leaving the SEC Website. The link you have selected is located on another server. Please click on the OK button below to proceed to the selected site. The SEC does not endorse this web site, its sponsor, or any of the policies, activities, products, or services offered on the site or by any advertiser on the site.","extHideIcons":false,"mailtoClass":"0","telClass":"","mailtoLabel":"(link sends email)","telLabel":"(link is a phone number)","extUseFontAwesome":false,"extIconPlacement":"append","extPreventOrphan":false,"extFaLinkClasses":"fa fa-external-link","extFaMailtoClasses":"fa fa-envelope-o","extAdditionalLinkClasses":"","extAdditionalMailtoClasses":"","extAdditionalTelClasses":"","extFaTelClasses":"fa fa-phone","allowedDomains":null,"extExcludeNoreferrer":""}},"field_group":{"html_element":{"mode":"default","context":"view","settings":{"classes":"rightrail-list","show_empty_fields":false,"id":"","element":"div","show_label":true,"label_element":"h2","label_element_classes":"","attributes":"","effect":"none","speed":"fast"}}},"user":{"uid":0,"permissionsHash":"e506dfd1572f94bd1f339f1a7483bfbded31d4a9d2bdfdca3fdbc235153380ee"}}
Skip to search field
Skip to main content
An official website of the United States government
Here’s how you know
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock
( Lock A locked padlock )
or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
SEC homepage
Menu
Close
Search SEC.gov & EDGAR
Search
Search Filings
Search Filings
Full Text Search
Latest Filings
Mutual Fund Search
Variable Insurance Products Search
SIC Codes
CIK Lookup
Public Dissemination Service (PDS)
Search Assistance
Submit Filings
Submit Filings
EDGAR Filer Management Portal
EDGAR Filing Portal
Online Forms Management Portal
EDGAR Next
Forms Index
Filer Support & Resources
Data & Research
Data & Research
Data Library
Statistics & Data Visualizations
Structured Data
Investment Management Data
Open Data at the SEC
Rules, Enforcement, & Compliance
Rules & Regulations
Rulemaking Activity
Submit Public Comments
Staff Guidance
No-Action, Interpretive, and Exemptive Letters
Self-Regulatory Organization Rulemaking
Public Petitions for Rulemaking
Enforcement & Litigation
Litigation Releases
Administrative Proceedings
Administrative Law Judge Orders and Initial Decisions
Trading Suspensions
Distributions to Harmed Investors
Receiverships
Compliance
Examination Priorities
Risk Alerts
Compliance Outreach Program
Proposed Rules
What's New
Whistleblower Program
Featured Topics
Featured Topics
Crypto Task Force
Cybersecurity
Market Structure Analytics
Saving and Investing for Military Personnel
Saving and Investing for Teachers
SEC-CFTC Harmonization Initiative
Treasury Clearing Implementation
About
About
Mission
Commissioners
Divisions & Offices
Division & Office Directors
Advisory Committees
Budget & Performance
Reports & Publications
Commission Votes
Contact the SEC
Careers
Submit a Tip or Complaint
Newsroom
|
Investors
Small Businesses
Whistleblowers
Newsroom
|
Investors
Small Businesses
Whistleblowers
Search SEC.gov & EDGAR
Search
More in this Section
Enforcement & Litigation
Litigation Releases
Administrative Proceedings
Administrative Law Judge Orders and Initial Decisions
Trading Suspensions
Distributions to Harmed Investors
Receiverships
Electronic Filings in Administrative Proceedings (eFAP)
Rules of Practice
Applications for Reentry
Reports of Investigations
Whistleblower Program
Public Alert: Unregistered Soliciting Entities (PAUSE)
SEC Action Lookup - Individuals (SALI)
Enforcement Data Delivery Standards
Small Businesses
Appellate Briefs
Amicus / Friend of the Court Briefs
Enforcement & Litigation
Litigation Releases
Administrative Proceedings
Administrative Law Judge Orders and Initial Decisions
Trading Suspensions
Distributions to Harmed Investors
Receiverships
Electronic Filings in Administrative Proceedings (eFAP)
Rules of Practice
Applications for Reentry
Reports of Investigations
Whistleblower Program
Public Alert: Unregistered Soliciting Entities (PAUSE)
SEC Action Lookup - Individuals (SALI)
Enforcement Data Delivery Standards
Small Businesses
Appellate Briefs
Amicus / Friend of the Court Briefs
Home
Enforcement and Litigation
Litigation Releases
Biomet, Inc.
Biomet, Inc.
U.S. Securities and Exchange Commission
Litigation Release No. 22306 / March 26, 2012
Accounting and Auditing Enforcement Release No. 3374 / March 26, 2012
Securities and Exchange Commission v. Biomet, Inc., Civil Action No. 1: 12-CV-00454 (D.D.C.)(RMC) (March 26, 2012)
SEC CHARGES MEDICAL DEVICE COMPANY BIOMET WITH FOREIGN BRIBERY
Washington, D.C., March 26, 2012 â€" The Securities and Exchange Commission today charged Warsaw, Ind.-based medical device company Biomet Inc. with violating the Foreign Corrupt Practices Act (FCPA) when its subsidiaries and agents bribed public doctors in Argentina, Brazil, and China for nearly a decade to win business.
Biomet, which primarily sells products used by orthopedic surgeons, agreed to pay more than $22 million to settle the SEC's charges as well as parallel criminal charges announced by the U.S. Department of Justice today. The charges arise from the SEC and DOJ's ongoing proactive global investigation into medical device companies bribing publicly-employed physicians.
The SEC alleges that Biomet and its four subsidiaries paid bribes from 2000 to August 2008, and employees and managers of all levels of the parent company and the subsidiaries were involved along with the distributors who sold Biomet's products. Biomet's compliance and internal audit functions failed to stop the payments to doctors even after learning about the illegal practices.
According to the SEC's complaint filed in federal court in Washington D.C., employees of Biomet Argentina SA paid kickbacks as high as 15 to 20 percent of each sale to publicly-employed doctors in Argentina. Phony invoices were used to justify the payments, and the bribes were falsely recorded as "consulting fees" or "commissions" in Biomet's books and records. Executives and internal auditors at Biomet's Indiana headquarters were aware of the payments as early as 2000, but failed to stop it.
The SEC alleges that Biomet's U.S. subsidiary Biomet International used a distributor to bribe publicly-employed doctors in Brazil by paying them as much as 10 to 20 percent of the value of their medical device purchases. Payments were openly discussed in communications between the distributor, Biomet International employees, and Biomet's executives and internal auditors in the U.S. For example, a February 2002 internal Biomet memorandum about a limited audit of the distributor's books stated:
"Brazilian Distributor makes payments to surgeons that may be considered as a kickback. These payments are made in cash that allows the surgeon to receive income tax free. …The accounting entry is to increase a prepaid expense account. In the consolidated financials sent to Biomet, these payments were reclassified to expense in the income statement."
According to the SEC's complaint, two additional subsidiaries â€" Biomet China and Scandimed AB â€" sold medical devices through a distributor in China who provided publicly-employed doctors with money and travel in exchange for their purchases of Biomet products. Beginning as early as 2001, the distributor exchanged e-mails with Biomet employees that explicitly described the bribes he was arranging on the company's behalf. For example, one e-mail stated:
"[Doctor] is the department head of [public hospital]. [Doctor] uses about 10 hips and knees a month and it's on an uptrend, as he told us over dinner a week ago. …Many key surgeons in Shanghai are buddies of his. A kind word on Biomet from him goes a long way for us. Dinner has been set for the evening of the 24th. It will be nice. But dinner aside, I've got to send him to Switzerland to visit his daughter."
The SEC alleges that some e-mails described the way that vendors would deliver cash to surgeons upon completion of surgery, and others discussed the amount of payments. The distributor explained in one e-mail that 25 percent in cash would be delivered to a surgeon upon completion of surgery. Biomet sponsored travel for 20 Chinese surgeons in 2007 to Spain, where a substantial part of the trip was devoted to sightseeing and other entertainment.
Biomet consented to the entry of a court order requiring payment of $4,432,998 in disgorgement and $1,142,733 in prejudgment interest. Biomet also is ordered to retain an independent compliance consultant for 18 months to review its FCPA compliance program, and is permanently enjoined from future violations of Sections 30A, 13(b)(2)(A), and 13(b)(2)(B) of the Securities Exchange Act of 1934. Biomet agreed to pay a $17.28 million fine to settle the criminal charges.
The SEC's investigation was conducted by Brent S. Mitchell with Tracy L. Price of the Enforcement Division's FCPA Unit and Reid A. Muoio. The SEC acknowledges the assistance of the U.S. Department of Justice's Fraud Section and the Federal Bureau of Investigation. The investigation into bribery in the medical device industry is continuing.
SEC Complaint in this matter
 
 
Resources
SEC Complaint
Return to top
SEC homepage
About the SEC
Budget & Performance
Careers
Commission Votes
Contact
Contracts
Transparency
Accessibility & Disability
Super Intelligence
FOIA
Inspector General
No FEAR Act Data
Ombuds
SEC Excess Personal Property Guidance
Websites
Investor.gov
Related Sites
USA.gov
Site Information
Plain Writing
Privacy & Security
Site Map
Stay connected. Sign up for email updates.
Your email address
Sign Up
X
Facebook
Instagram
RSS
YouTube
Email Updates